Novartis AG is 87.9x more valuable than Viking Therapeutics, Inc. by market capitalization ($283.13 B vs $3.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VKTX | NVS |
|---|---|---|
| Market cap | $3.22 B | $283.13 B |
| US-listed rank | #1747 | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$359.64M | - |
| SEC filings | 627 | 947 |
Novartis AG is 87.9x more valuable than Viking Therapeutics, Inc. by market capitalization ($283.13 B vs $3.22 B).
Full pages: Viking Therapeutics, Inc. and Novartis AG, or browse the full rankings.